Sugi Predict

Sugi Predict / Compounds / SCHEMBL4473771

SCHEMBL4473771

SCHEMBL4473771

COC(=O)c1ccccc1Nc1sc(C(=O)c2ccccn2)c(N)c1C#N

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.50
▸ ALDH1A1 P00352 8/20 0.47
▸ MAPT P10636 6/20 0.47
▸ GAA P10253 2/20 0.47
▸ MELK Q14680 7/20 0.47
▸ POLB P06746 1/20 0.46
▸ HPGD P15428 2/20 0.44
▸ MAPK1 P28482 2/20 0.44
▸ HTT P42858 1/20 0.44
▸ MEN1 O00255 1/20 0.41
▸ ALOX12 P18054 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ ALOX15 P16050 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ CYP1A2 P05177 2/20 0.40
▸ CYP2C19 P33261 2/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP2D6 P10635 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4486561 0.86 MELK (0.51) LMNAALDH1A1MAPTGAAMELK
SCHEMBL4487251 0.84 LMNA (0.54) LMNAALDH1A1MAPTGAAMELK
SCHEMBL4472300 0.84 MELK (0.66) LMNAALDH1A1MAPTGAAMELK
SCHEMBL4476868 0.82 MAPT (0.57) LMNAALDH1A1MAPTGAAMELK
SCHEMBL4472091 0.79 ALDH1A1 (0.47) LMNAALDH1A1MAPTGAAMELK
SCHEMBL4461289 0.78 BRAF (0.53) LMNAALDH1A1MAPTGAAMELK
SCHEMBL4472002 0.78 ALDH1A1 (0.46) LMNAALDH1A1MAPTGAAMELK
SCHEMBL4475075 0.78 ALDH1A1 (0.59) LMNAALDH1A1MAPTGAAMELK
SCHEMBL4477411 0.77 MAPT (0.57) LMNAALDH1A1MAPTGAAMELK
SCHEMBL4478111 0.75 MELK (0.51) LMNAALDH1A1MAPTGAAMELK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8470821-B2 PDE4B inhibitors and uses therefor PLEXXIKON INC. (US) 2013-06-25 — — US disclosed
US-8470821-B2 PDE4B inhibitors and uses therefor PLEXXIKON INC. (US) 2013-06-25 — — US disclosed
US-8470821-B2 PDE4B inhibitors and uses therefor PLEXXIKON INC. (US) 2013-06-25 — — US disclosed
US-20090286793-A1 PDE4B INHIBITORS AND USES THEREFOR PLEXXIKON, INC. 2009-11-19 — — US disclosed
US-20090286793-A1 PDE4B INHIBITORS AND USES THEREFOR PLEXXIKON, INC. 2009-11-19 — — US disclosed
US-20090286793-A1 PDE4B INHIBITORS AND USES THEREFOR PLEXXIKON, INC. 2009-11-19 — — US disclosed
US-7585859-B2 PDE4B inhibitors and uses therefor PLEXXIKON, INC. (US) 2009-09-08 — — US disclosed
US-7585859-B2 PDE4B inhibitors and uses therefor PLEXXIKON, INC. (US) 2009-09-08 — — US disclosed
US-7585859-B2 PDE4B inhibitors and uses therefor PLEXXIKON, INC. (US) 2009-09-08 — — US disclosed
US-20060041006-A1 PDE4B inhibitors and uses therefor PLEXXIKON, INC. 2006-02-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286793-A1 PDE4B INHIBITORS AND USES THEREFOR PDE4B, PDE7B, PDE4A LMNA 2349/4885ALDH1A1 802/4885MAPT 3524/4885
US-20060041006-A1 PDE4B inhibitors and uses therefor PDE4B, PDE7B, PDE4A LMNA 2349/4885ALDH1A1 802/4885MAPT 3524/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.